
Most patients taking valbenazine reported meaningful relief from how tardive dyskinesia affects daily life, with gains across social, emotional, and physical domains.

Dr Bron is the health economics and outcomes research senior director at Neurocrine.

Most patients taking valbenazine reported meaningful relief from how tardive dyskinesia affects daily life, with gains across social, emotional, and physical domains.